First European Congress on Hereditary ATTR amyloidosis

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP

Nadine Attal

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I1

Published on: 2 November 2015

Neuropathic phenotypes and natural history of FAP

David Adams

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I2

Published on: 2 November 2015

Which assessment for the carriers: the cardiac view

Arnt V Kristen

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I3

Published on: 2 November 2015

When to decide to enroll a TTR-FAP patient in a Clinical Trial?

Juan Buades

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I4

Published on: 2 November 2015

Preimplantation genetic diagnosis for TTR-FAP in Portugal

Filipa Carvalho

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I5

Published on: 2 November 2015

TTR-FAP: liver transplant vs oral medication. How and when

Teresa Coelho

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I6

Published on: 2 November 2015

Which assessment for the carriers ? The point of view of the neurologist

Isabel Conceicão

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I7

Published on: 2 November 2015

ATTR-FAP: liver transplantation vs oral medication, how and when

Bo Goran Erikzon

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I8

Published on: 2 November 2015

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)

Natália Ferreira

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I9

Published on: 2 November 2015

Imaging cardiac ATTR amyloid

Philip N Hawkins

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I10

Published on: 2 November 2015

Minimal assessment of index cases: the point of view of the neurologist

Ernst Hund

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I11

Published on: 2 November 2015

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis

Luisa Lobato

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I12

Published on: 2 November 2015

Do we need to demonstrate Amyloid in tissue?

Laurent Magy

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I13

Published on: 2 November 2015

Emerging CNS involvement in FAP-TTR long survival patients

Luisa Maia

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I14

Published on: 2 November 2015

Biopsy experience in a FAP endemic area

Manuel Melo Pires

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I15

Published on: 2 November 2015

New tools to diagnose and follow FAC patients: biomarkers

Giampaolo Merlini

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I16

Published on: 2 November 2015

New therapeutic perspectives – amyloid removal

Mark Pepys

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I17

Published on: 2 November 2015

Cardiologic Phenotypes and Natural History of FAC

Claudio Rapezzi

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I18

Published on: 2 November 2015

TTR amyloidosis: a scientific journey since Andrade

Maria João Saraiva

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I19

Published on: 2 November 2015

Guidelines for genetic counselling in ATTR amyloidosis

Jorge Sequeiros

Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I20

Published on: 2 November 2015